OBJECTIVES: There are few reports on optimal surgical approaches to bilateral pulmonary metastasis and the sequences used in the operation. The aim of this study was to evaluate the feasibility of the thoracoscopic bilateral approach to pulmonary metastasis.
INTRODUCTION
Bilateral presentation of pulmonary metastatic nodules is a common situation for surgeons when they are considering pulmonary metastasectomy. Until now, there have been no definite guidelines for the treatment of bilateral disease except that resectability is the most important factor to improving the outcome but the debate continues about the oncological benefits of aggressive exploration in advanced disease [1] [2] [3] .
A recent trend in most thoracic surgical fields has been to change to video-assisted thoracoscopic surgery (VATS) [2] . However, the VATS approach is still controversial for metastasectomy because there are 20-50% non-imaged nodules present during open surgery and palpation of the lung has been the standard for detecting non-imaged nodules [4] . In contrast, proponents of the thoracoscopic approach have insisted that the surgical outcomes are not inferior to open surgery and the quality of life of the patients is also an important prognostic factor in long-term survivors as far as having a better postoperative course for VATS surgery [5] . In addition, with the introduction of high-resolution thin-section computed tomography (CT) scans, most metastatic nodules can be detected and discriminated accurately on preoperative images in certain types of primary tumours [6] . In addition, there has been a lot of controversy over the advantages of routine one-stage bilateral lung exploration [7] and few reports on optimal surgical approaches and sequences specific to bilateral disease for minimizing the operative morbidity related with postoperative quality of life. It has been established that one-stage bilateral exploration by sternotomy or clamshell incision can provide excellent exposure for detecting metastatic nodules even though these open procedures might result in relatively high morbidity [8] . Additionally, there are no proven benefits to one-stage exploration over two-stage operation in terms of survival and intrathoracic recurrences.
However, we focused on the potential benefits of VATS, which enable one-stage exploration for oligo-metastatic bilateral disease with less postoperative morbidity and better functional outcomes. The feasibility or indications of this approach for bilateral disease are not fully understood and little is known about the outcomes in the case of VATS resection. In this study, based on our experiences of bilateral VATS, we retrospectively analysed the surgical outcomes of bilateral pulmonary metastasectomy (BPM) with thoracoscopy with the aim to assess the role and limitation of this procedure in bilateral disease.
MATERIALS AND METHODS
Our Institutional Review Board approved this study and waived the requirement for patient consent (IRB No. H-1303-001-470). From our database for the pulmonary metastasectomy registry of 510 patients from June 1998 to February 2013, 174 patients underwent a planned BPM with various approaches, including thoracotomy (n = 81), thoracoscopy (n = 61), combined thoracotomy and thoracoscopy (n = 28), or sternotomy (n = 4). Open surgery for lung palpation had been a standard surgical approach for pulmonary metastasectomy in all patients; however, we adopted bilateral thoracoscopic metastasectomy from 2006 in selected patients. We selected 61 patients who proceeded with a planned thoracoscopic BPM using a one-stage (n = 52) or two-stage operation (n = 9). The most common primary tumour was colorectal cancer (n = 18) as a non-sarcomatous lesion followed by hepatocellular carcinoma (n = 9), breast cancer (n = 5), renal cell carcinoma (n = 5), gynaecological cancer (squamous cell) (n = 5), adenoid cystic cancer (n = 2), biliary cancer (n = 2) and germ cell tumour (n = 1). Sarcomatous lesions, such as osteosarcoma (n = 10), soft tissue sarcoma (n = 3) and chondrosarcoma (n = 2), were included in our series. The median disease interval from the operation time for the primary tumours was 23 (0-156) months (Table 1 ). All patients had been evaluated by 1-mm cut thin-section chest CT scan and positron emission tomography (PET) scan within 1 month. The surgical decisions for the approach used and the sequence of VATS to the bilateral multiple lesions (BMs) were made based on (i) the peripheral location of the lesions being within the outer one-third from the visceral pleura, (ii) a size <3 or 4 cm, which was amenable to VATS, and (iii) five or less metastatic lesions imaged on the preoperative 1-mm cut thin-section chest CT scans. We planned the bilateral operations after considering comorbidity and remnant pulmonary reserve after the operation. Fifty-two patients underwent BPM with one-stage thoracoscopy and 9 patients underwent BPM using two-stage thoracoscopic operation with a median interval of 34 days . The thorax, which we approached first, was the side that required lesser resection to safely enable complete bilateral operation. We performed wedge resection with thoracoscopy under both lateral decubitus positions and repositioned sequentially in the one-stage operation. Although there was limited value for finger palpation through the port, we tried to palpate the lung to detect subpleural nodules or sense the tactile feedback of the instruments when grasping the lung parenchyma. Preoperative localizations, such as hook wire or dye injection, were rarely used in our series. Mediastinal lymph nodes were partially sampled if involvement was suspected in the preoperative imaging. If there were more than five lesions on each thorax on the preoperative CT scan or intraoperative one-lung ventilation was not appropriate for one-stage bilateral surgery, we delayed the surgery for the contralateral thorax. In the two-stage procedures, operation for the contralateral thorax usually was performed within a 2-to 4-week interval and pulmonary function was rechecked before the second operation. We checked a baseline CT scan after metastasectomy at 3 months postoperatively and every 3 months for 2 years.
Demographic and operative data were analysed and the outcomes including hospital stay, early postoperative morbidity, survival, postoperative pulmonary function and episodes of pneumonia within 6 months postoperatively were evaluated in the study population. We analysed the fate of the imaged and resected nodules grouped by the number of lesions and the type of primary tumours to identify the predictors for pathologically unilateral disease, recurrence patterns and re-metastasectomy. Mortality and morbidity were classified with a developed system that graded the presence and severity of thoracic morbidity and mortality [9] based on the Clavien-Dindo classification of surgical adverse events. Pulmonary function, as indicated by forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) was examined preoperatively in all patients and postoperative pulmonary reserve was reassessed 6 months after completion of BPM, except in patients who were severely compromised by disease progression. We analysed the intrathoracic recurrence patterns and prognostic factors after bilateral VATS by tumour type, number of lesions and disease-free interval and evaluated the survival and intrathoracic recurrence by primary tumour histology (sarcoma vs non-sarcoma) and the number of metastatic nodules using the log-rank test.
RESULTS
There were imaged bilateral single lesions (BSs) in 17 patients and three or more BMs in 44 patients on the preoperative thin-section CT scan. Table 2 presents the diameters, PET findings, and the number of resected and true metastatic nodules, which were classified by the number of lesions on the preoperative CT scan. There were 12 (70.6%) and 22 (63.6%) patients who had bilateral nodules seen on the PET in the BS group and BM group, respectively. We were able to complete the one-stage VATS in all patients with BS and resected more nodules in 7 patients (41.2%). There were 9 patients (20.5%) who underwent two-stage VATS in the BM group and 13 patients (29.5%) had more non-imaged nodules. From the pathological examinations, there were 5 patients who showed unilateral disease and 11 patients with BSs. In the BM group, there were 4 patients with unilateral disease. From the multivariate analysis for predicting factors for unilateral disease among the preoperative findings, only unilateral lesions on the PET scan could predict unilateral disease in this study ( Table 3) . The median length of hospital stay was 5 (2-14) days for the one-stage operation and 8 (6-13) days for the two-stage operation. There were no operative mortalities and 13 morbidities developed during the postoperative days. Eleven patients showed grade II minor complications including prolonged air leaks (n = 3), pneumonia (n = 2), postoperative atrial fibrillation (n = 2), ileus (n = 2), pulmonary thromboembolism (n = 1) and haemoptysis (n = 1). Two patients developed grade III major complications, pneumonia and prolonged effusion, which were controlled by medical treatment without mortality (Table 4 ). The indicators for pulmonary function showed a reduction in the mean value for FVC and FEV1 of respectively 7.6% and 6.7% in patients with BS, while the reduction in BMs patients was 14.4% and 15.4% (FVC: P = 0.08; FEV1: P = 0.06) (Fig. 1) . The median follow-up time was 25 (3-77) months, and 9 patients (14.8%) experienced a pneumonia event that needed readmission within 6 months after discharge. Intrathoracic recurrences developed in 27 patients (44.3%) during follow-up. There were 8 unilateral (47.1%) and 1 bilateral (5.9%) recurrences in pathological BSs, while 9 unilateral (20.5%) and 9 bilateral (20.5%) recurrences in pathological BMs, and 16 patients underwent reoperation for intrathoracic recurrences (6 patients (35.3%) in the BS and 10 (22.7%) in the BM group). When grouping the number of true metastatic lesions (BSs vs three or more) for pathological results or the histological type of primary tumours (sarcoma and non-sarcoma), there were no significant differences in intrathoracic recurrences (P = 0.5407 and P = 0.6771, respectively) (Fig. 2) . The sarcomatous histology (P = 0.039), diameters (P = 0.042) and the bilateral uptake on PET scan (P = 0.035) were the significant prognostic factors for intrathoracic recurrences in our series ( Table 5 ). The survival curves estimated by the Kaplan-Meier method were also not different statistically between the groups by the number of metastases and histological types (P = 0.8763 and P = 0.4574, respectively) (Fig. 3) .
DISCUSSION
Current recommendations for surgical approaches to bilateral disease suggest the use of two-stage bilateral thoracotomy or onestage operation via sternotomy or a clamshell incision [10] . The results from our bilateral VATS experiences show that one-or twostage thoracoscopic operation could be a feasible option in oligometastatic peripherally located bilateral disease. To date, while there may be small solitary bilateral pulmonary diseases that could successfully undergo one-stage operation via a minimally invasive approach [11] , it is unclear whether a bilateral thoracoscopic approach to pulmonary metastases could be a feasible option as a curative tool. One-stage bilateral thoracotomy is not preferred because of the potential for increased postoperative morbidity, whereas sternotomy, which allows palpation of the whole lung, is an approach used for one-stage resection in bilateral pulmonary disease [1] . Another option is the use of clamshell incisions that provide more exposure of the entire lung than that provided by sternotomy [12] . However, trans-sternal clamshell incisions might result in increased sternal pain and wound dehiscence. Recently, we changed our surgical strategy to bilateral disease in selected patients. The rationale for the application of bilateral VATS in our study was based on the accuracy of modern imaging techniques (thin-section chest CT scan and PET scan) and the controversy over survival outcomes from open bilateral exploration [7] . To achieve the resection goal of not missing small nodules, manual lung palpation is necessary in pulmonary metastasis. Preoperative evaluation even with high-quality, thin-section chest CT scans could not detect metastatic nodules in 22-35% of patients [13] . If possible, complete nodule eradication should be achieved and there is no doubt that open surgery, such as thoracotomy or sternotomy regardless of the sequences, should be a standard approach to resect suspected nodules by palpation of the lung. In practice, more non-imaged nodules could be detected when using manual palpation during open thoracotomy than when using VATS [14] . Most prospective trials [4, 15] between open and VATS metastasectomy have indicated the limitations of VATS. However, it is difficult to determine whether aggressive resection of millimeter-sized non-imaged nodules could improve the survival or freedom from intrathoracic recurrences in a patient with BMs [16] .
Unfortunately, there is little information available on the role and extent of bilateral surgery in the presence of hidden lesions on preoperative imaging studies. PET scan might be a predictor for true metastatic lesions in radiological unilateral disease in our study; however, it has a limited role in small-sized lesions usually <10 mm [17] . In our study, we were able to predict BSs <3 cm to be a good indication for one-stage operation and preoperative PET scan could help determine the status of the lesion [18] . The lesions originating from a sarcomatous histology might be a potential risk factor for recurrences; re-metastasectomy could be performed in selected patients and this strategy in bilateral disease could be a feasible option for initial bilateral aggressive exploration by open surgery.
The outcome of VATS-based metastasectomy, in a few series studies [5, 19] , was reported to be comparable with that from thoracotomy in cases with single or several lesions. Despite the potential for incomplete resection with VATS and the potential to detect non-imaged nodules during thoracotomy with palpation, the reported similar outcomes of the VATS series compared with those of open surgery might indicate that the role of surgery may be limited because it is impossible to eradicate all metastatic foci by surgery, even by open palpation.
Although it is evident that open palpation could guarantee a high detection rate of hidden metastatic nodules, it has been reported that the outcomes of surgical control for pulmonary metastasis depend on various factors, such as primary tumour histology and their disease status, the number of metastases and resectability. Thus, the results from a small population with a mixed primary tumour pathology in our study did not demonstrate that the bilateral VATS approach is superior or can supplant the current surgical recommendations in all cases of bilateral disease. Bilateral open surgery is still a standard for bilateral disease. Nevertheless, we suggest that a selective approach to bilateral disease should be based on the benefits of the approach to the overall disease course and current considerations regarding pulmonary metastasectomy.
The thoracoscopic approach to bilateral disease in our study consisted of mainly one-stage operation under both lateral decubitus positions sequentially. Our indications for bilateral VATS were oligometastatic (five or less in one hemithorax on the preoperative CT scan), and peripherally located (outer one-third from visceral pleura) BMs. Although this evaluation was not a comparative result, the outcomes showed the potential advantages: short metastasectomy duration by the one-stage approach, reduced postoperative morbidity by VATS and good postoperative pulmonary reserve. From our results, it is estimated that one-stage bilateral VATS metastasectomies require a median of 5 days to complete bilateral surgery and the two-stage operation needs an additional 3 days to complete surgery. The one-stage bilateral operation by VATS could minimize the length of the hospital stay, and it could be beneficial to patients by reducing the surgical stress of the two-stage operation or open procedures. The low level of postoperative morbidity and respiratory pulmonary complications could also affect the postoperative quality of life of patients and may improve the patients' compliance to the planned treatment following metastasectomy. In addition, the remnant pulmonary reserve after a bilateral VATS approach may be particularly beneficial allowing for further operation or reoperation for recurrent disease. Our results showed 14.4 and 15.4% reductions, respectively, in the values of the FVC and FEV1 at 6 months postoperatively in patients who had three or more BMs resected. Sixteen (26.2%) patients in our study have had a second operation due to intrathoracic recurrences by open surgery or VATS. A good postoperative pulmonary reserve may be important in the overall treatment course of patients who need additional chemotherapy, radiotherapy or surgery. In addition, reduced pulmonary function could be a risk factor of respiratory complications and may exacerbate related symptoms postoperatively although they completed bilateral clearances [20] .
The disadvantages of one-stage thoracoscopic operation are that there are some intraoperative management issues including the malfunction of the chest tube placement and increased anaesthetic time. In addition, the one-stage approach to bilateral disease by VATS is not yet a routine procedure and has not been widely adopted because of the potential for an intraoperative event, such as adverse hypotensive conditions and cardiac arrhythmia during the procedure [21] . However, we did not experience any adverse events during the procedure and surgeons may more readily adopt a one-stage VATS-based approach to bilateral disease if they are sufficiently familiar with the conventional VATS approach.
In summary, despite the limitations of this study, a VATS approach to bilateral disease should be considered as a feasible option because it can result in reduced hospital stays, low perioperative morbidity and acceptable long-term outcomes. Potentially, the one-stage approach could replace the routine use of staged bilateral open surgery in patients with small-sized and few bilateral metastatic nodules.
